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K-Cl	cotransport	activity	in	rbc	is	a	major	determinant	of	rbc	volume	and	density.	Pathologic	activation	of	
erythroid	K-Cl	cotransport	activity	in	sickle	cell	disease	contributes	to	rbc	dehydration	and	cell	sickling.	To	
address	the	roles	of	individual	K-Cl	cotransporter	isoforms	in	rbc	volume	homeostasis,	we	disrupted	the	
Kcc1	and	Kcc3	genes	in	mice.	As	rbc	K-Cl	cotransport	activity	was	undiminished	in	Kcc1–/–	mice,	decreased	in	
Kcc3–/– mice,	and	almost	completely	abolished	in	mice	lacking	both	isoforms,	we	conclude	that	K-Cl	cotrans-
port	activity	of	mouse	rbc	is	mediated	largely	by	KCC3.	Whereas	rbc	of	either	Kcc1–/–	or	Kcc3–/–	mice	were	of	
normal	density,	rbc	of	Kcc1–/–Kcc3–/–	mice	exhibited	defective	volume	regulation,	including	increased	mean	
corpuscular	volume,	decreased	density,	and	increased	susceptibility	to	osmotic	lysis.	K-Cl	cotransport	activ-
ity	was	increased	in	rbc	of	SAD	mice,	which	are	transgenic	for	a	hypersickling	human	hemoglobin	S	variant.	
Kcc1–/–Kcc3–/–	SAD	rbc	lacked	nearly	all	K-Cl	cotransport	activity	and	exhibited	normalized	values	of	mean	
corpuscular	volume,	corpuscular	hemoglobin	concentration	mean,	and	K+	content.	Although	disruption	of	
K-Cl	cotransport	rescued	the	dehydration	phenotype	of	most	SAD	rbc,	the	proportion	of	the	densest	red	blood	
cell	population	remained	unaffected.
Introduction
K-Cl cotransporters (KCCs) mediate electroneutral symport of K+ 
and Cl– ions across the plasma membrane that is mostly outward-
ly directed and was originally described in rbc (1–3). K-Cl cotrans-
port is mediated in a wide range of tissues by the polypeptide 
products of the 4 homologous SLC12 cation cotransporter super-
family genes SLC12A4/KCC1, SLC12A5/KCC2, SLC12A6/KCC3, 
and SLC12A7/KCC4 (4). These proteins contribute to regulatory 
volume decrease, transepithelial ion transport, and the control 
of the cytoplasmic Cl– concentration ([Cl–]i). Loss-of-function 
mutations in human KCC3 cause Andermann syndrome, which 
is characterized by severe peripheral neuropathy with variable 
agenesis of the corpus callosum (5). These clinical features are 
partially reproduced in Kcc3–/– mice (5, 6), which also display arte-
rial hypertension and a slowly progressive deafness (6, 7). Two 
main 5′-splice variants of KCC3 have been identified, KCC3a and 
KCC3b, with distinct expression profiles (8). Specific roles of 
KCC1 have remained unknown in the absence of a Kcc1–/– mouse 
or a KCC1-associated human disease. The ubiquitous expression 
of KCC1 suggested a general role in cell volume regulation (9–11). 
In addition to KCC1, KCC3 has also been detected in rbc (11). rbc 
K-Cl cotransport has been implicated in the physiological reduc-
tion of cell volume accompanying maturation of reticulocytes 
and nascent erythrocytes (12, 13). K-Cl cotransport is substan-
tially reduced in mature, circulating rbc but can be activated by 
urea, hypotonic challenge, thiol-reactive reagents such as N-eth-
ylmaleimide, oxidants, and nonselective protein kinase inhibitors 
such as staurosporine (14, 15).
Erythroid K-Cl cotransport activity is increased in sickle cell 
disease (SCD) (16) and is thought to contribute to rbc dehydra-
tion and the formation of sickle cells (17, 18). SCD is generally 
caused by the hemoglobin (Hb) β-chain E6V mutation. This 
sickle Hb (HbS) causes rbc to change shape upon deoxygen-
ation because of polymerization of the abnormal HbS. Sickled 
blood cells cause acute and chronic organ dysfunction due to 
vasoocclusive events in the microcirculation. The duration of 
the postoxygenation delay preceding the rapid phase of HbS 
polymerization is inversely proportional to the 30th-to-50th 
exponential power of HbS concentration. Thus, small increases 
in sickle cell volume, e.g., by inhibition of K-Cl cotransport, 
resulting in small decreases in intracellular HbS concentration 
(19), may greatly prolong the delay time of HbS polymerization. 
This prolongation, in turn, is hypothesized to delay deforma-
tion and sickling of sickle rbc until they escape the capillaries 
into larger venules, or even until they can be reoxygenated in the 
pulmonary circulation (20, 21). Hence, therapeutic inhibition 
of erythroid K-Cl cotransport has been proposed as an adjunct 
therapy for SCD. However, specific inhibitors of high potency 
are not yet available.
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To study more definitively the role of erythroid K-Cl cotrans-
port in health and SCD, we have created a Kcc1–/– mouse model. 
Through studies of this and the Kcc3–/– mouse, we show that KCC3 
is the predominant KCC of mouse erythrocytes. Disruption of 
both rbc KCCs in mice resulted in impaired rbc volume regula-
tion. To address the suggested role of K-Cl cotransport in SCD, 
we crossed KCC1- and KCC3-KO mice into the SAD mouse model 
of SCD, which reproduces the dehydrated red cell phenotype of 
human SCD (22, 23). Although disruption of K-Cl cotransport res-
cued the dehydration phenotype of most SAD rbc, the proportion 
of the densest red blood cell population remained unaffected.
Results
Kcc1–/– mice are viable and fertile. Deletion of the Slc12a4 gene exons 
4 and 5, encoding the first 2 putative transmembrane spans of 
KCC1, results in a frameshift and premature termination (Figure 
1A). Homologous recombination was verified by Southern blot 
analysis (Figure 1B). Northern blot analysis using a full-length 
KCC1 probe demonstrated that the transcript of the recombined 
allele was unstable, as shown for liver (Figure 1C) and brain (data 
not shown). Immunoblot analysis confirmed the broad expression 
pattern of the KCC1 polypeptide and its absence in Kcc1–/– mice 
(Figure 1D). Kcc1–/– mice were born at the expected Mendelian ratio 
Figure 1
Generation of Kcc1–/– mice. (A) Partial genomic 
organization of Slc12a4 (top) and the targeting 
construct (middle). Exons are shown as vertical 
bars, loxP sites as arrowheads. Transient Cre 
expression resulted in excision of exons 4 and 5 
(bottom), producing a frameshift and premature 
stop. DTA, diphtheria toxin A cassette. (B) An 
additional EcoRV site was exploited for Southern 
blot analysis and resulted in the approximately 
6.5-kb KO compared with the approximately 
10-kb Kcc1+/+ fragment with the probe shown in 
A. (C) Northern blot analysis of Kcc1+/+, Kcc1+/–, 
and Kcc1–/– liver tissue with a full-length KCC1 
probe revealed some residual aberrant tran-
script. (D) A membrane protein immunoblot 
with a KCC1 antibody confirmed the absence of 
KCC1 in tissues of Kcc1–/– mice. (E) rbc mem-
brane protein immunoblot demonstrated KCC3b 
expression in WT rbc and absence of KCC3a, 
KCC2, and KCC4 in erythrocytes of WT, Kcc1–/– 
Kcc3–/–, and SADKcc1–/–Kcc3–/– mice. Actin 
served as a loading control. Kidney served as 
a positive control for KCC1 and KCC3b, brain 
for KCC2 and KCC3a, and lung for KCC4. (F 
and G) Expression levels of KCC1 and KCC3 
proteins in rbc ghosts of various genotypes. (F) 
KCC3b protein level was upregulated in ghosts 
lacking KCC1, but KCC1 levels were unchanged 
in KCC3-KO ghosts. (G) Levels of both KCC1 
and KCC3b proteins were increased in ghosts 
from SAD mice. Protein levels were determined 
by Western blot analysis (see Supplemental 
Figure 1) and normalized to actin. Bars repre-
sent arithmetic means from 6 mice normalized 
to WT. Error bars represent SEM. *P < 0.05, 
**P < 0.005 compared with WT.
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(25.5% Kcc1+/+, 49.0% Kcc1+/–, and 25.5% Kcc1–/–; n = 168) and were 
viable and fertile. Their body weight and mortality were identical 
to those of  WT (Kcc1+/+) littermates. They were indistinguishable 
in appearance and showed no motor deficits as assayed by rotarod 
or motor activity (data not shown). Auditory threshold, electro-
retinogram responses to light stimuli, and seizure threshold in 
response to the seizure-inducing agent flurothyl were unaltered 
(data not shown). Histological investigation of all major organ 
systems revealed no obvious abnormalities (data not shown). No 
signs of overt osteopetrosis were noted.
Kcc1–/–Kcc3–/– mice resemble Kcc3–/– mice in overall phenotype but 
have an increased mortality. The widespread expression pattern 
of KCC1 overlaps with that of KCC3, including in rbc (9–11). 
Immunoblot analysis of WT rbc ghost membranes demonstrat-
ed the presence of both KCC1 and KCC3b, but not of KCC3a, 
KCC2, and KCC4 (Figure 1E). Quantification of protein levels in 
Figure 2
K-Cl cotransport activity in rbc of WT and KO mice. K-Cl cotransport was determined by measuring K+ efflux in the presence or absence of 
Cl– (replaced with SFA–) in isotonic or hypotonic conditions and in the presence of staurosporine (1 μM) or urea (500 mM) added to the isotonic 
solution. Gray bars indicate a significant difference between stimulated and isotonic K+ fluxes in the presence of Cl–. Black bars indicate a signifi-
cant difference between K+ fluxes in a single condition in the presence and absence of Cl–. WT K-Cl cotransport activity (A) was unaltered in rbc 
of Kcc1–/– mice (B). (C, D, and E) Disruption of Kcc3 reduced K-Cl cotransport activity in all conditions examined, with an apparent gene-dosage 
effect. (F) In rbc of Kcc1–/–Kcc3–/– mice, equivalent K+ fluxes in the presence and absence of Cl– indicated complete loss of K-Cl cotransport 
activity. Numbers in parentheses refer to the number of independent samples in each category. 
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Kcc1–/– ghosts revealed upregulation of KCC3b, whereas KCC1 
protein levels were unchanged in Kcc3–/– ghosts (Figure 1F and 
Supplemental Figure 1; supplemental material available online 
with this article; doi:10.1172/JCI30630DS1). Coomassie stain-
ing of ghost membranes subjected to PAGE did not reveal any 
grossly evident alteration of polypeptide profile among differ-
ent genotypes (Supplemental Figure 2). To generate mice defi-
cient for both rbc KCCs, Kcc1–/–Kcc3+/– siblings were intercrossed. 
Kcc1–/–Kcc3–/– mice were born at the expected Mendelian ratio 
(25.0% Kcc1–/–, 50.6% Kcc1–/–Kcc3+/–, and 24.4% Kcc1–/–Kcc3–/–; 
n = 223), excluding a lethal developmental phenotype in the dou-
ble-KO. The phenotype of Kcc1–/–Kcc3–/– mice closely resembled the 
extensively described phenotype of Kcc3–/– mice (6, 7). Although 
Kcc1–/–Kcc3–/– mice were fertile, litters from Kcc1–/–Kcc3–/– matings 
were very rare, and litter sizes were small. Kcc1–/–Kcc3–/– mice had 
an increased mortality (21.9%; n = 89) during the first 5 weeks of 
life compared with Kcc3–/– (11.1%; n = 121), Kcc1–/– (<1.0%), and 
WT mice (<1.0%). Throughout postnatal development, the body 
weight of Kcc1–/–Kcc3–/– mice was less than that of Kcc1–/– or Kcc3–/– 
littermates. P28 body weight of Kcc1–/–Kcc3–/– mice was 10.8 ± 0.5 g 
versus 12.8 ± 0.7 g for Kcc3–/– (P < 0.05), 14.7 ± 1.1 g for Kcc1–/–, and 
14.5 ± 1.2 g for WT mice (n = 10 in each group). At age 8 weeks, 
the mean body weight of Kcc1–/–Kcc3–/– mice had increased to 
18.2 ± 1.0 g compared with weights of 21.8 ± 1.1 g for Kcc3–/– 
(n = 10; P < 0.05), 23.3 ± 0.6 g for Kcc1–/– (n = 10), and 23.8 ± 0.5 g 
for WT mice (n = 12). The ratio of spleen weight to body weight 
(3.77% ± 0.41% in WT; n = 10) was reduced in Kcc1–/–Kcc3–/– mice 
(2.76% ± 0.18%; n = 10; P < 0.05) but not in Kcc1–/– (3.85% ± 0.49%; 
n = 21) or Kcc3–/– mice (3.54% ± 0.24% n = 11).
rbc K-Cl cotransport is mediated mainly by KCC3, and to a lesser extent by 
KCC1. rbc K-Cl cotransport, measured as Cl–-dependent K+ efflux 
in the presence of 1 mM ouabain (to inhibit the Na+/K+-ATPase) 
and 0.1 mM bumetanide (to inhibit NaK2Cl cotransport), was 
investigated under 3 conditions known to stimulate K-Cl cotrans-
port, i.e., extracellular hypotonicity (~25% decrease in osmolarity), 
0.5 M extracellular urea, and 1 μM staurosporine. Unexpectedly, 
K-Cl cotransport activity in Kcc1–/– rbc was moderately increased 
at extracellular hypotonicity (P < 0.05) (Figure 2, A and B), corre-
sponding to the upregulation of KCC3b polypeptide abundance in 
Kcc1–/– rbc (Figure 1F). Under the other experimental conditions, 
K-Cl cotransport activity in Kcc1–/– rbc was similar to that of WT 
(Figure 2, A and B). However, K-Cl cotransport was moderately 
decreased in rbc of Kcc3+/– and Kcc1–/–Kcc3+/– mice (Figure 2, C and 
D) and decreased to a greater degree in rbc of Kcc3–/– mice under 
all conditions examined (Figure 2E). Hypotonicity-activated K-Cl 
cotransport appeared to be abolished in Kcc3–/– rbc, but stauro-
sporine and urea stimulated a small remnant of K-Cl cotransport 
activity. However, all K-Cl cotransport activity stimulated by these 
3 maneuvers was absent in rbc of Kcc1–/–Kcc3–/– mice (Figure 2F).
Kcc1–/–Kcc3–/– mice have reduced 
rbc numbers but are not anemic. rbc 
counts of Kcc1–/–Kcc3–/– mice, but 
not of single KO littermates, were 
mildly decreased compared with 
those of WT mice (P < 0.05; Table 
1). However, these lower values 
did not reflect anemia, since Hb 
values in all strains were within 
the normal ranges for the paren-
tal C57BL6/J and SV129 strains 
(Mouse Genome Informatics Database, The Jackson Laboratory; 
http://www.informatics.jax.org/). The lack of a hemolytic anemia 
in Kcc1–/–Kcc3–/– mice was corroborated by WT values of serum bili-
rubin and lactate dehydrogenase (data not shown) and by normal 
reticulocyte counts as determined by brilliant cresyl violet staining 
of blood smears and by ADVIA analysis. Histological analysis of 
spleen, liver, and bone marrow by Prussian blue staining did not 
reveal increased iron deposition as a consequence of increased rbc 
turnover (ref. 24 and data not shown).
Disruption of K-Cl cotransport affects rbc volume. Although rbc mean 
corpuscular volume (MCV) of Kcc1–/– mice and Kcc3–/– mice was 
not altered, MCV was significantly increased in Kcc1–/–Kcc3–/– mice 
(53.3 ± 0.4 fl; n = 10) compared with WT values (50.4 ± 0.6 fl; 
n = 10; P < 0.005) (Table 1). The reticulocyte MCV as determined 
by ADVIA analysis was similarly unchanged in Kcc1–/– (61.8 ± 0.6 
fl; n = 31) compared with WT mice (61.2 ± 0.6, n = 35) but elevated 
in Kcc1–/–Kcc3–/– mice (65.1 ± 0.7 fl; n = 23; P < 0.001), with a corre-
sponding reduction in reticulocyte corpuscular Hb concentration 
mean (CHCM). The density distribution of rbc was determined for 
Kcc1–/–, Kcc3–/–, and Kcc1–/–Kcc3–/– mice using 2 methods. Whereas 
the phthalate density distribution of rbc was unaltered in Kcc1–/– 
and Kcc3–/– rbc, Kcc1–/–Kcc3–/– rbc distributions were shifted toward 
lower densities, suggesting that loss of both KCC1 and KCC3 is nec-
essary to alter steady-state volume homeostasis of rbc (Figure 3A). 
The shift of K-Cl cotransport–deficient rbc toward lower densities 
was confirmed by discontinuous Stractan gradient centrifugation 
(Figure 3B) and quantitative analysis of the resulting fractions (Fig-
ure 3C). To address the role of K-Cl cotransport in determination 
of rbc surface area/volume ratio, rbc osmotic fragility was tested by 
exposure to NaCl concentrations ranging from 154 mM (0.90%) to 
60 mM (0.35%). Whereas the osmotic resistance of rbc from Kcc1–/– 
or Kcc3–/– mice resembled that of control rbc, the osmotic resistance 
of Kcc1–/–Kcc3–/– rbc was decreased (Figure 3D).
The densest rbc of SAD mice are not rescued by disruption of rbc K-Cl 
cotransport. rbc dehydration produced by elevated K-Cl cotransport 
activity is thought to be a key factor in accelerated HbS polym-
erization in deoxygenated sickle cells (17). Indeed, overall K-Cl 
cotransport activity was markedly elevated in rbc of SAD mice at 
basal isotonic conditions (Figure 4A), as previously shown for rbc 
of both SAD mice (25) and SCD patients (26, 27). This may be due 
in part to upregulation of protein levels of both KCC1 and KCC3b 
in SAD rbc (Figure 1G). However, the increased levels of these pro-
teins may be largely influenced by the roughly 2-fold increase in 
SAD mice of reticulocytes (Tables 1 and 2), cells that express more 
cotransport activity than mature rbc. Activators of K-Cl cotrans-
port, hypotonicity or urea, did not increase K-Cl cotransport 
activity in SAD rbc to levels higher than those observed in WT rbc 
(compare Figure 4A and Figure 2A). As observed for rbc of WT and 
Kcc1–/–Kcc3–/– mice, rbc of SAD or Kcc1–/–Kcc3–/– SAD mice (desig-
Table 1
Hematological indices of Kcc-KO and WT mice
Genotype	 rbc	(106/ml)	 Hgb	(g/dl)	 Hct	(%)	 MCV	(fl)	 MCH	(pg)	 CHCM	(g/dl)	 Retic	(%)
WT 9.6 ± 0.2 14.6 ± 0.3 48.5 ± 0.7 50.4 ± 0.6 15.2 ± 0.2 27.8 ± 0.2 3.2 ± 0.4
Kcc1–/– 9.4 ± 0.3 15.3 ± 0.4 47.7 ± 1.2 51.2 ± 0.9 16.4 ± 0.2 28.7 ± 0.2 3.0 ± 0.4
Kcc3–/– 9.1 ± 0.2 14.0 ± 0.2 46.4 ± 0.6 51.3 ± 0.6 15.5 ± 0.2 27.3 ± 0.3 3.4 ± 0.5
Kcc1–/–Kcc3–/– 8.4 ± 0.1A 14.1 ± 0.2 46.4 ± 0.7 53.3 ± 0.4A 16.8 ± 0.1 26.7 ± 0.2 3.2 ± 0.5
AP ≤ 0.005 compared with WT. Hgb, Hb content; Hct, hematocrit; MCH, mean corpuscular Hb; Retic, reticulocytes.
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nated SADKcc1–/–Kcc3–/– mice) did not express detectable amounts 
of KCC2 or KCC4 protein (Figure 1E). Disruption of KCC1 in 
SAD mice did not affect basal rbc K-Cl cotransport activity or the 
magnitude of stimulated activity (Figure 4B). Neither hypotonic-
ity nor urea increased K-Cl cotransport activity in SADKcc3–/– rbc 
(Figure 4C). Residual basal K-Cl cotransport activity was evident in 
SADKcc3–/– rbc and was further reduced in SADKcc1–/–Kcc3–/– rbc 
(Figure 4D). K-Cl cotransport activity in SADKcc1–/–Kcc3–/– rbc was 
not sensitive to stimulation by hypotonicity or urea (Figure 4D). 
Consistent with previous studies on human sickle cells (16) and 
SAD rbc (23), the K+ content of SAD rbc was substantially reduced 
compared with that of controls (Figure 4E). Neither a deficiency 
of KCC1 or KCC3 alone (Supplemental Table 1) nor disruption of 
both KCCs affected K+ content of non-SAD rbc (Figure 4E). How-
ever, lack of KCC3 partially restored SAD rbc K+ content; and in 
SADKcc1–/–Kcc3–/– rbc, K+ content was comparable to that in WT 
(Figure 4E). Na+ content did not differ significantly among red 
cells from SAD mice and SAD mice lacking one or both KCC poly-
peptides (Supplemental Table 1).
The MCV of SAD rbc (44.8 ± 0.7 fl) was decreased compared with 
that of WT (50.4 ± 0.6 fl; P < 0.005) (Table 2). CHCM was cor-
respondingly increased 
(32.4 ± 0.7 g/dl for SAD 
versus 27.8 ± 0.2 g/dl for 
WT; P < 0.005). Absence of 
KCC1 and KCC3 in SAD 
mice raised MCV to val-
ues comparable to those 
in WT mice and signifi-
cantly decreased CHCM. 
In contrast, the absence 
of either KCC1 or KCC3 
in SAD mice did not alter 
MCV, although CHCM of SADKcc3–/– mice (31.7 ± 0.2 g/dl) was 
slightly decreased compared with that of SAD mice (32.4 ± 0.7 
g/dl; P < 0.005) (Table 2). As dense rbc are most likely to sickle 
upon deoxygenation, we determined the rbc density profiles for 
WT, SADKcc1–/–, SADKcc3–/–, and SADKcc1–/–Kcc3–/– mice. SAD rbc 
were of higher density (Figure 5, A–C) than WT rbc, as previously 
reported (22, 28). Compared with SAD rbc, the density profile of 
most SADKcc1–/–Kcc3–/– rbc mice was shifted toward lower-density 
values, but there was no significant effect of the double KO on the 
density of the densest 10%–15% rbc. The increased osmotic resis-
tance of SAD rbc (Figure 5D), similar to that of human sickle cells, 
was partially normalized toward WT values in SAD cells lacking 
Kcc1 and Kcc3 (Figure 5C).
Discussion
KCCs regulate cell volume and contribute to transepithelial ion 
transport. Early Northern blot analysis studies revealed that KCC1 
transcripts are ubiquitously expressed, leading investigators to 
suggest a fundamental role in cell volume regulation (29), in par-
ticular in rbc (9). To address the physiological roles of Kcc1, we dis-
rupted the Kcc1 gene in mice. Surprisingly, Kcc1–/– mice lacked any 
Figure 3
Hematologic characterization of Kcc-
KO mice. (A) rbc densities determined 
by centrifugation through phthalate mix-
tures of defined density. (B) rbc densi-
ties determined by centrifugation through 
discontinuous Stractan gradients. FI, 
fraction I. (C) Distinct rbc bands were 
collected and the rbc numbers quantified 
to evaluate relative number of rbc per 
fraction. Kcc1–/– and Kcc3–/– rbc densi-
ties were indistinguishable from WT, 
but Kcc1–/–Kcc3–/– rbc densities were 
reduced. (D) Osmotic lysis curve shows 
significantly increased osmotic sensi-
tivity only for rbc lacking both KCCs. 
*P ≤ 0.05; **P ≤ 0.005.
Table 2
Hematological indices of SAD mice of various Kcc genotypes
Genotype	 rbc	(106/ml)	 Hgb	(g/dl)	 Hct	(%)	 MCV	(fl)	 MCH	(pg)	 CHCM	(g/dl)	 Retic	(%)
SAD 9.6 ± 0.2 14.5 ± 0.2 42.8 ± 0.6 44.8 ± 0.7 15.9 ± 0.2 32.4 ± 0.7 7.3 ± 0.5
SADKcc1–/– 9.3 ± 0.3 15.4 ± 0.2 44.4 ± 0.9 46.8 ± 0.8 16.6 ± 0.5 29.5 ± 1.1 5.2 ± 0.4
SADKcc3–/– 9.2 ± 0.1 14.0 ± 0.3 42.4 ± 0.7 46.3 ± 0.3 15.3 ± 0.1 31.7 ± 0.2A 7.0 ± 0.6
SADKcc1–/–Kcc3–/– 8.9 ± 0.3 14.2 ± 0.5 43.6 ± 1.4 49.0 ± 0.7B 15.9 ± 0.2 29.6 ± 0.5B 4.5 ± 0.4B
In SADKcc1–/–Kcc3–/– mice, MCV was increased and CHCM decreased compared with levels in SAD mice. AP ≤ 0.05,  
BP ≤ 0.005 compared with SAD.
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obvious clinical phenotype. In vitro analysis of Kcc1–/– rbc revealed 
no reduction in K-Cl cotransport activity under basal or stimu-
lated conditions (Figure 2B).
Although KCC4 was detected in human erythroid precursor 
cells and reticulocytes by RT-PCR (30), our immunoblot analysis 
detected only KCC1 and KCC3b polypeptides in mouse rbc. K-Cl 
cotransport activity was partially decreased in Kcc3+/– rbc, more 
severely reduced in Kcc3–/– rbc (Figure 2, C and E), but undimin-
ished in Kcc1–/– rbc. However, under hypotonic stimulation, K-Cl 
cotransport activity was surprisingly increased in Kcc1–/– com-
pared with WT rbc, likely reflecting increased KCC3b protein lev-
els in rbc lacking KCC1. In our experimental conditions, KCC3b 
was the dominant erythroid KCC, consistent with the biophysical 
characteristics of sheep rbc K-Cl cotransport, which better match 
the known properties of KCC3 than those of KCC1. For instance, 
the rank order of anion-dependent K+ transport in sheep rbc, 
[Br– > Cl– > I– > SCN–], coincides better with the 
rank order of anion-dependent K+ transport for 
human KCC3a [Br– > Cl– > (I– = SCN–)] (8) than 
that for rabbit KCC1 [Cl– > (SCN = Br–) > I–] (31, 
32) expressed in Xenopus oocytes. However, the 
KCC gene product responsible for most erythroid 
K-Cl cotransport may be species specific, as the 
anion rank order measured in human rbc, [Cl– > 
Br– > I–] (2), suggests a significant contribution by 
KCC1. Possible species differences in regulation 
of erythroid K-Cl cotransport are highlighted by 
a recent study of human rbc from Andermann 
syndrome patients with truncating mutations 
in the KCC3 gene (33). This study documented 
decreased N-ethylmaleimide–stimulated K-Cl 
cotransport without reduction of staurospo-
rine-stimulated K-Cl cotransport, in contrast to 
our results with mouse Kcc3–/– rbc. Kcc3–/– rbc 
displayed some K-Cl cotransport activity (Figure 
2E), which was absent in rbc of Kcc1–/–Kcc3–/– mice 
and thus likely reflects KCC1 activity. Since K-Cl 
cotransport was measured in total rbc, different 
contributions of KCC1 and KCC3 to the K-Cl cotransport activity 
of rbc subpopulations of different developmental age or density 
cannot be excluded. Indeed, overall K-Cl cotransport activity was 
shown to be higher in reticulocytes and young erythrocytes but 
almost inactive in nonstimulated mature sheep rbc (14, 15). This 
observation led to the speculation that K-Cl cotransport reduces 
rbc volume during rbc maturation (12, 13). Erythrocyte MCV was 
elevated in Kcc1–/–Kcc3–/– mice (Table 1), but not in Kcc1–/– and 
Kcc3–/– mice, suggesting an abnormal regulation of rbc volume. 
Bone marrow histology did not indicate any morphological evi-
dence for an rbc maturation defect (data not shown), although 
Kcc1–/–Kcc3–/– mice exhibited a small change in hematocrit. The 
density profile shift toward lower densities in Kcc1–/–Kcc3–/– rbc 
supports the idea that KCC1 and KCC3 are also active in non-
stimulated mature rbc. Indeed, the rbc osmotic fragility of Kcc1–/–
Kcc3–/– mice was increased in vitro.
Figure 4
rbc K-Cl cotransport activity and K+ content of SAD 
mice of various Kcc genotypes. (A–D) K+ efflux from 
rbc measured as described in Methods in the pres-
ence of Cl– or upon its substitution by SFA–, mea-
sured under isotonic or hypotonic conditions and in 
the presence of 500 mM urea added to the isotonic 
solutions. Gray bars indicate a significant difference 
between isotonic and stimulated K+ fluxes. Black bars 
indicate a significant difference between K+ fluxes in 
a single condition in the presence and absence of Cl–. 
(A) The elevated isotonic K-Cl cotransport activity of 
SAD rbc (compare with WT rbc in Figure 2A) was fur-
ther stimulated by hypotonicity and by urea. Absence 
of KCC1 had minimal effect on K-Cl cotransport 
activity (B), whereas absence of KCC3 reduced K-Cl 
cotransport activity (C), and absence of both KCC1 
and KCC3 nearly abolished cotransport activity (D). 
(E) Disruption of KCC1 and KCC3 did not alter rbc 
K+ content in the absence of the SAD transgene but 
rescued nearly completely the reduced K+ content of 
SAD rbc. *P ≤ 0.05.
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The rate of sickling of deoxygenated rbc strongly depends on 
the rbc HbS concentration. Small reductions in the HbS concen-
tration produced by therapeutic elevation of rbc volume have 
improved the pathological changes of sickle disease (34). As K-Cl 
cotransport activity is increased in rbc from SCD patients (35), 
K-Cl cotransport–mediated rbc dehydration is believed to be 
important in controlling the rate of deoxygenation-induced red 
cell sickling. The KCC may therefore be an attractive pharmacolog-
ical target in the treatment of SCD. An increase in rbc Mg2+ content 
([Mg2+]i) is known to inhibit K-Cl cotransport activity, and Mg2+ 
was shown to be decreased in rbc of some SCD patients (36). Oral 
Mg2+ supplementation elevated erythrocyte [Mg2+]i, decreased rbc 
K-Cl cotransport activity, and prevented rbc dehydration in SAD 
mice and in a small group of patients (25, 37). However, no small-
molecule inhibitors of K-Cl cotransport with sufficient specificity 
and potency are available to allow clinical trial. To investigate the 
contribution of K-Cl cotransport to the pathogenesis of SCD, we 
disrupted rbc K-Cl cotransport in the SAD mouse model of sickle 
disease. SAD mice have circulating irreversibly sickled cells and 
develop chronic organ and tissue pathology resembling that of 
human sickle disease (22). Our data confirm that K-Cl cotransport 
activity is increased in SAD mice and demonstrate that this is at 
least in part due to an upregulation of KCC1 and KCC3b protein 
levels.  Erythrocyte MCV was increased in SADKcc1–/–Kcc3–/– mice 
compared with SAD mice (Table 2). The increased rbc osmotic 
resistance of SAD rbc (an expression of cell dehydration) was 
modified in SADKcc1–/–Kcc3–/– rbc and approached that of WT 
rbc (Figure 5D). Mean corpuscular Hb concentration was strongly 
elevated in SAD mice, as observed previously by Trudel et al. (28) 
and De Franceschi et al. (23). Loss of KCC1 and KCC3 in SAD mice 
significantly decreased CHCM, but CHCM of SADKcc1–/–Kcc3–/– 
mice remained slightly higher than that of WT controls (Table 
2). Density distribution analysis clearly demonstrated that loss of 
erythroid K-Cl cotransport in SAD mice increased the proportion 
of light, less-dense rbc subpopulations (Figure 5, A–C). However, 
the fraction containing the densest, dehydrated rbc remained 
unaltered. Lew and Bookchin have suggested that this dense frac-
tion of human sickle cells originates from fast-track dehydration 
of reticulocytes mediated in substantial part by the elevated K-Cl 
cotransport activity of these young cells (17). The current data sug-
gest that formation of the densest red cell fraction in SAD mice 
does not require K-Cl cotransport. Comparative investigation of 
the transport activity of specific density fractions of human sickle 
and mouse SAD red cells may further elucidate the relative contri-
butions to dehydration of K-Cl cotransport and KCNN4 (Gardos 
channel) activity. Results of preliminary in vitro dithionite sickling 
experiments (38) trended toward a reduced proportion of abnor-
mally shaped deoxygenated rbc from SADKcc1–/–Kcc3–/– mice, 
which, however, did not differ statistically from that of deoxygen-
ated SAD rbc (data not shown). The severe neurodegeneration of 
Kcc1–/–Kcc3–/– and SADKcc1–/–Kcc3–/– mice, which resembles that 
described for Kcc3–/– mice, precluded an in vivo analysis of rbc sick-
ling under conditions of acute or chronic hypoxia.
Our work demonstrates the important contribution of K-Cl 
cotransport to the regulation of mouse rbc volume, an effect that 
is enhanced in the presence of transgenic human sickling Hb SAD 
(HbSAD). This volume regulation is mediated principally by KCC3 
and to a lesser degree by KCC1. The genetic disruption of K-Cl 
cotransport results in increased MCV, decreased CHCM and cell 
density, and increased susceptibility to osmotic lysis. Although 
Figure 5
Hematological characterization of 
SAD mice of various Kcc geno-
types. (A) Phthalate density profile 
of SAD mice of various Kcc geno-
types. (B) rbc density distribution 
revealed by discontinuous Stractan 
gradient centrifugation. (C) Disrup-
tion of erythroid K-Cl cotransport in 
SADKcc1–/–Kcc3–/– mice shifted the 
density distribution profile toward 
lower densities only in the low-den-
sity fractions, but not in high-den-
sity fractions. (D) Osmotic fragility 
curve. The osmotic resistance phe-
notype of SAD rbc was partially res-
cued by the absence of both KCC3 
and KCC1. *P ≤ 0.05; **P ≤ 0.005.
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these changes are also observed in K-Cl cotransport–deficient SAD 
red cells, the proportion of densest rbc in SAD mice remained undi-
minished. Hence, activation of K-Cl cotransport is a main determi-
nant for the volume regulation of young rbc in SAD mice but may 
be not required for the generation of the densest fraction of rbc 
in SAD mice. This result, if extrapolated to human sickle disease, 
predicts that inhibitors of K-Cl cotransport used alone will not 
be maximally effective in reversing the red cell dehydration that 
predisposes to sickling. Inhibitors of another major volume regu-
latory pathway of red cells, the Ca2+-activated K+ channel KCNN4, 
attenuated the cell dehydration phenotype of sickle cells both in 
humans and in SAD mice (26, 39), but studies on sickle-cell mice 
lacking erythroid Kcnn4 expression are not yet available. Inhibition 
of both volume-regulatory pathways in sickle red cells may suffice 
to normalize the cell dehydration phenotype and maximize the 
delay time for deoxygenation-induced sickling.
Methods
All animal experiments were approved by Amt für Gesundheit und Verbrauch-
erschutz, University of Hamburg, and by the Institutional Animal Care and 
Use Committee (IACUC) of Beth Israel Deaconess Medical Center. 
Disruption of Slc12a4 in mice. A genomic clone of murine Slc12a4, the gene 
encoding KCC1, was isolated from a 129/Sv mouse genomic library (λFixII; 
Stratagene). The region encompassing exons 4 and 5 was flanked by loxP 
sites by insertion of a loxP site into the intron between exons 5 and 6 by 
PCR mutagenesis and by insertion of a floxed neomycin resistance (neo) 
cassette between exons 3 and 4 into a blunted genomic BamHI restriction 
site. A diphtheria toxin A (DTA) cassette was introduced at the 5′ end of the 
targeting construct as a negative selection marker. The linearized vector 
was electroporated into R1 ES cells (derived from the SVJ strain). G418-
resistant clones that had undergone homologous recombination (Figure 1) 
were transfected with a plasmid expressing Cre-recombinase. Resulting 
clones were checked for the extent of DNA excision. Cells with a deletion 
of a fragment encompassing exons 4 and 5 and the neo cassette were used 
for the generation of the KO line. The recombinational excision resulted 
in a Kcc1–/– gene encoding a protein lacking aa 115–182, with a frameshift 
in codon 182 leading to termination after 36 residues of neosequence. 
These cells were injected into C57BL/6 blastocysts that were implanted 
into foster mothers. Resulting male chimeras were bred with C57BL/6 
females. Heterozygous animals stemming from 2 different ES cell clones 
were inbred to yield mutant mouse lines. Routine genotyping was done 
by multiplex PCR using primers mKCC1-Seq12-s (5′-AGGCCAGAGC-
CAAGGAGTCTG-3′), mKCC1-r (5′-GGAGATTACAGGAGTGTACTG-3′), 
and mKCC1-Seq13-a (5′-ATCCCAGCAACCATATGGTGG-3′) to yield 
amplification products of 355 bp (WT) or 270 bp (KO).
Additional animal models used in this study. The generation of Kcc3–/– mice 
and SAD mice has been described previously (6, 28). Mating of Kcc1+/–Kcc3+/– 
mice resulted in Kcc1–/–, Kcc3–/–, and Kcc1–/–Kcc3–/– mice and the appropriate 
controls. SAD mice were mated with Kcc1+/–, Kcc3+/–, and Kcc1+/–Kcc3+/– mice 
to obtain SADKcc1–/–, SADKcc3–/–, and SADKcc1–/–Kcc3–/– mice. Studies were 
performed in a mixed 129SV/C57BL6 background using littermates (Fig-
ures 3–5) or age- and sex-matched animals of the same genetic backgrounds 
(Figure 2) as controls. SAD mouse genotyping was performed by 2 types of 
diagnostic multiplex genomic PCR. The human HbSAD transgene primer 
pair sad-s1 (5′-GACTCCTGAGGAGAAGTCTGCCGT-3′) and SAD-Seq6-a 
(5′-CACCGAGCACTTTCTTGCCATGAGC-3′) with annealing at 55°C 
yielded a 210-bp SAD transgene amplification product, while the control 
primer pair of mKA1-Seq37 (5′-AACAGCAGCGAGCCCGAGTAGTG-3′) 
and mKA1-Seq38-a (5′-TAAGAACTAGACCCAGGGTACAATG-3′) yielded 
a 388-bp control mouse genomic amplification product. Alternatively, the 
SAD primer pair SAD.A (5′-CCAACTCCTAAGCCAGTGCCAGAAG-3′) 
and SAD.B (5′-ACATCAAGGGTCCCATAGACTCACC-3′) with annealing 
at 60°C yielded a 685-bp SAD transgene amplification product, while the 
control primer pair of KCC1.E20F (5′-ACCTCCGCCTGGAAGCTGAAG-3′) 
and KCC1.CtM (5′-CTCAGGARTAGATGGTGATGACTTC-3′) yielded 
a 1,297-bp mouse KCC1 genomic amplification product. Human Hb α2 
genotyping was also performed to verify cosegregation of both transgenes. 
Primers HBA2-Seq1-s (5′-CCGGTCAACTTCAAGGTGAGC-3′) and HBA2-
Seq2-a (5′-TACCGAGGCTCCAGCTTAACG-3′) yielded a 301-bp band 
specific for Hb α2.
Northern blot analysis. Total RNA was prepared from WT, Kcc1+/–, and 
Kcc1–/– liver. Ten micrograms each was subjected to agarose electrophoresis 
and subsequently blotted onto a nylon membrane as described previously 
(6) and hybridized with a murine full-length Kcc1 cDNA probe.
Antibodies. Polyclonal antibodies were raised in rabbits against the 
N-terminal mouse KCC1 peptide sequence PVDGPRRGDYDNLEG that 
was coupled to BSA via a C-terminal cysteine. One rabbit serum specifi-
cally detected KCC1 in membrane-enriched protein lysates in immunoblot 
analysis as confirmed using Kcc1–/– tissues. Likewise, antibodies were 
raised against N-terminal peptide sequences of murine KCC3a (RVRFSS-
RESVPETSR) and KCC3b (KVEDPEEGAAGPLSP). Peptide affinity-puri-
fied antibodies were used in immunoblots: rb α-KCC1, rb α-KCC3a, 
rb α-KCC3b, rb α-KCC2, and gp α-KCC4 (all 1:500) (6, 40, 41); rb α-actin 
(1:4,000; Sigma-Aldrich).
Immunoblot. Membrane proteins were enriched from tissues as described 
previously (6), except that prior to tissue dissection, animals were deeply 
anesthetized followed by transcardial perfusion with PBS to clear tissues 
from blood. rbc ghosts were prepared from venous blood drawn from the 
vena cava into heparinized syringes. Blood cells were harvested by cen-
trifugation, and ghosts were prepared by several cycles of washing with 
H2O followed by centrifugation until the red heme color cleared. Equal 
amounts of protein were separated by SDS–PAGE, blotted onto nitrocel-
lulose, and labeled with primary antibodies. Secondary antibodies were 
conjugated to HRP (Chemicon) and detected by chemiluminescence 
(SuperSignal West; Pierce). Quantification was done with the Chemi-
Smart 5000 image acquisition system (Vilber Lourmat) and ImageJ 1.36b 
software (http://rsb.info.nih.gov/ij/).
Density distribution profile. Venous blood was drawn from retro-orbital 
venous plexus with heparinized hematocrit capillaries (Brand) and col-
lected into EDTA-coated tubes (SARSTEDT) to prevent coagulation. The 
density distribution was determined using mixtures of methyl phthalate 
(Fluka; Sigma-Aldrich) and di-η-butyl phthalate (Sigma-Aldrich) (42). rbc 
were spun through phthalate ester mixtures with densities ranging from 
1.086 to 1.118 g/ml at 12,000 g for 15 minutes in a hematocrit centrifuge 
(Biofuge Haemo; Heraeus), and relative heights of rbc columns below and 
above each phthalate ester phase were quantified.
Discontinuous Stractan gradient. Stractan/polyarabinogalactan (Fluka; 
Sigma-Aldrich) solutions and buffered saline with potassium and glu-
cose (BSKG; in mM: 134 NaCl, 8.6 Na2HPO4, 1.4 NaH2PO4, 5 KCl, 
10 glucose, and 1 % BSA; pH 7.4; osmolarity 290–295 mOsm) were prepared 
as described previously (22). Nine different 400-μl fractions of Stractan/
BSKG solutions with densities ranging from 1.0822 g/ml to 1.1102 g/ml 
were successively layered into 4.2 ml ultraclear centrifuge tubes (Beckman 
Coulter). Venous blood was drawn retro-orbitally with heparinized hema-
tocrit capillaries and collected into EDTA-coated tubes. Twenty microliters 
blood diluted with 180 μl BSKG was layered on top of the Stractan gradi-
ent and centrifuged 30 minutes at 23,400 g in a TST 60.4 rotor (Kontron) 
at 20°C. For quantitative analysis, experiments were repeated with six 
600-μl Stractan fractions with densities ranging from 1.082 to 1.100 g/ml 
for rbc from WT, Kcc1–/–, Kcc3–/–, and Kcc1–/–Kcc3–/– mice and with densities 
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ranging from 1.093 to 1.110 for rbc from SAD, SADKcc1–/–, SADKcc3–/–, 
and SADKcc1–/–Kcc3–/– mice. Distinct rbc bands were collected and the rbc 
numbers quantified using cell counter Z1 (Beckman Coulter) to evaluate 
relative number of rbc per fraction.
Resistance to osmotic lysis. Venous blood drawn retro-orbitally was collect-
ed into reaction tubes containing approximately one-fourth of the final 
volume of 4.3% (wt/vol) Na citrate. Twenty microliters citrated blood was 
incubated for 2 hours at 37°C in solutions of NaCl in water, concentra-
tions ranging from 0.0% to 0.7% (wt/vol). rbc were pelleted at 1,000 g for 
5 minutes, and the supernatants were incubated in a 0.1% SDS solution 
containing (in mM) 0.8 KCN, 0.6 K3Fe(CN)6, 1 KH2PO4 to transform Hb 
into cyanohemoglobin, which was quantified photometrically at a wave-
length of 546 nm. The degree of rbc hemolysis was normalized to com-
plete hemolysis in H2O.
Hematological parameters. Venous blood was drawn retro-orbitally and 
collected into EDTA-coated tubes. Hemogram and reticulocyte counts 
were analyzed automatically using the ADVIA 120 Hematology System 
(Bayer). Reticulocyte counts were also determined by brilliant cresyl violet 
staining of blood smears.
Determination of rbc K-Cl cotransport activity. K-Cl cotransport activity, 
defined as net ouabain- and bumetanide-resistant K+ efflux, was examined 
as described previously (43). In brief, venous blood was drawn retro-orbital-
ly into EDTA-coated tubes or via cardiac or caval puncture into heparin-
ized tubes. Twenty-four microliters of whole blood was diluted with 276 μl 
normal mouse saline (in mM: 165 NaCl, 2 KCl, 0.15 MgCl, 10 Tris/Mops; 
pH 7.4 at 25°C) to evaluate hematological parameters using the ADVIA 
120 Hematology System (Bayer). The remaining rbc were washed 4–6 times 
in choline wash solution (CWS; in mM: 172 choline chloride, 10 sucrose, 
10 Tris-Mops; pH 7.4 at 4°C) and resuspended in CWS to approximately 
50% hematocrit. rbc were suspended at 2.5% hematocrit in ice-cold isotonic 
(340 mOsm; 160 mM NaCl) or hypotonic (260 mOsm; 115 mM NaCl) NaCl 
solutions containing (in mM): 1 MgCl2, 10 glucose, 1 ouabain, 0.01 or 0.1 
bumetanide, and 10 Tris-Mops (pH 7.4 at 37°C). KCC fluxes in the pres-
ence of 0.01 mM bumetanide (Figure 4) were consistently approximately 
10% higher than in the presence of 0.1 mM bumetanide (Figure 2) for red 
cells of WT, SAD, and Kcc1–/– mice, whether stimulated by hypotonic-
ity, staurosporine, or urea. These results were consistent with equivalent, 
low bumetanide sensitivities of KCC1 and KCC3 activities under our net 
efflux assay conditions of nominally K+ free flux medium. Some isotonic 
solutions contained 1 μM staurosporine or 500 mM urea as indicated. In 
Cl–-free solutions, sulfamate (SFA–) substituted for Cl–. rbc suspensions 
were transferred into a water bath and incubated at 37°C. Triplicate sam-
ples of cell suspension were taken after 5 and 25 minutes, centrifuged at 
700 g for 4 minutes at 4°C, and the supernatants harvested for measure-
ment of the K+ concentrations by atomic absorption spectroscopy (Perkin-
Elmer). K+ efflux rates were calculated from the linear regression slopes of 
medium K+ concentrations at 5 and 25 minutes. In room air CO2-equili-
brated sulfamate solutions at 37°C, intracellular chloride was effectively 
depleted throughout the efflux measurement period (43, 44).
Determination of rbc cation content. rbc were washed 4 times in CWS and 
thereafter resuspended at a hematocrit of 50% in CWS. rbc suspensions 
were diluted 50-fold in 0.02% Pluronic PE 6400 (BASF), a nonionic deter-
gent, to lyse rbc. Supernatants were further diluted 10-fold in 0.02% 
Pluronic PE 6400 to determine K+ concentration by atomic absorption 
spectrometry (PerkinElmer).
Statistics. Values are expressed as mean ± SEM. For unpaired 2-sample 
2-tailed Student’s t tests, P ≤ 0.05 was considered significant. Values of K+ 
efflux and of hematological indices were compared among all genotypes 
by least-squares ANOVA with proportionate weighting for constant coef-
ficient of variation and with Bonferroni-Holm and Bonferroni-Hochberg 
step-down corrections for multiple samples (JMP [version 6; SAS Institute] 
and Excel [2003; Microsoft] yielded similar results). For ANOVA, P < 0.05 
was considered significant. Density distribution profile, quantitative anal-
yses of Stractan gradients, and osmotic resistance were compared by 2-way 
ANOVA with Bonferroni correction.
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